Type I diabetes mellitus decreases in vivo macrophage-to-feces reverse cholesterol transport despite increased biliary sterol secretion in mice

Jan Freark de Boer, Wijtske Annema, Marijke Schreurs, Jelske N. van der Veen, Markus van der Giet, Niels Nijstad, Folkert Kuipers, Uwe J. F. Tietge*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

26 Citations (Scopus)

Abstract

Type I diabetes mellitus (T1DM) increases atherosclerotic cardiovascular disease; however, the underlying pathophysiology is still incompletely understood. We investigated whether experimental T1DM impacts HDL-mediated reverse cholesterol transport (RCT). C57BL/6J mice with alloxan-induced T1DM had higher plasma cholesterol levels (P <0.05), particularly within HDL, and increased hepatic cholesterol content (P <0.001). T1DM resulted in increased bile flow (2.1-fold; P <0.05) and biliary secretion of bile acids (BA, 10.5-fold; P <0.001), phospholipids (4.5-fold; P <0.001), and cholesterol (5.5-fold; P <0.05). Hepatic cholesterol synthesis was unaltered, whereas BA synthesis was increased in T1DM (P <0.001). Mass fecal BA output was significantly higher in T1DM mice (1.5-fold; P <0.05), fecal neutral sterol excretion did not change due to increased intestinal cholesterol absorption (2.1-fold; P <0.05). Overall in vivo macrophage-to-feces RCT, using [H-3] cholesterol-loaded primary mouse macrophage foam cells, was 20% lower in T1DM (P <0.05), mainly due to reduced tracer excretion within BA (P <0.05). In vitro experiments revealed unchanged cholesterol efflux toward T1DM HDL, whereas scavenger receptor class BI-mediated selective uptake from T1DM HDL was lower in vitro and in vivo (HDL kinetic experiments) (P <0.05), conceivably due to increased glycation of HDL-associated proteins (+65%, P <0.01). In summary, despite higher mass biliary sterol secretion T1DM impairs macrophage-to-feces RCT, mainly by decreasing hepatic selective uptake, a mechanism conceivably contributing to increased cardiovascular disease in T1DM.-Freark de Boer, J., W. Annema, M. Schreurs, J. N. van der Veen, M. van der Giet, N. Nijstad, F. Kuipers, and U. J. F. Tietge. Type I diabetes mellitus decreases in vivo macrophage-to-feces reverse cholesterol transport despite increased biliary sterol secretion in mice. J. Lipid Res. 2012. 53: 348-357.

Original languageEnglish
Pages (from-to)348-357
Number of pages10
JournalJournal of Lipid Research
Volume53
Issue number3
DOIs
Publication statusPublished - Mar-2012

Keywords

  • high density lipoproteins
  • bile acids
  • cardiovascular disease
  • atherosclerosis
  • neutral sterols
  • glucose
  • efflux
  • selective uptake
  • liver
  • bile
  • HIGH-DENSITY-LIPOPROTEIN
  • APOLIPOPROTEIN-A-I
  • PRACTICE RESEARCH DATABASE
  • BILE-ACID METABOLISM
  • PHOSPHOLIPASE A(2)
  • SELECTIVE UPTAKE
  • ANTIINFLAMMATORY PROPERTIES
  • DEPENDENT VASORELAXATION
  • CARDIOVASCULAR-DISEASE
  • OXIDATIVE STRESS

Fingerprint

Dive into the research topics of 'Type I diabetes mellitus decreases in vivo macrophage-to-feces reverse cholesterol transport despite increased biliary sterol secretion in mice'. Together they form a unique fingerprint.

Cite this